Fundraising Fox
🦊/People
Sign in

Teri Willey

Investor

P2C Managing Director & Officer at Pathway to Cures · Investing Member - Rising America I, II and III Fund and FemTech II Fund at Portfolia · Director at Kovina Therapeutics

Bloomington, Indiana, United States

Find your path to Teri

295 people in our graph share verified history with Teri — schools, employers, funds. One of them is your warm intro.

René KuijtenunlockedTeri: together at Oncode Institute (2018–2026)
Teri: together at IU Ventures
×4Teri: together at Portfolia
Teri: together at Mount Sinai

About

Willey joined NBDF in November 2022 to launch and lead Pathway to Cures. She has over 35 years of experience commercializing early-stage research, previously serving as founding managing director of IU Ventures' Indiana Philanthropic Venture Fund, founding chief executive of Cambridge Enterprise Ltd, and co-founder of ARCH Development Partners.

Director at Kovina Therapeutics

Intro paths

→

In turn, Teri can intro founders to Kovina Therapeutics's investors below.

Kovina Therapeutics's investors · 2

Elevate VenturesIndianapolis · $20K – $2M checks · since 2021IU VenturesBloomington · since 2021

Co-founders at Kovina Therapeutics

EAElliot Androphy
Elliot AndrophyChief Scientific Officer

Experience

  1. Pathway to CuresInvestment Advisorcurrent2026 — presentNew York, New York, United States
  2. Pathway to CuresFounding Managing Director and Officer2022 — 2026New York, United States
  3. Pathway to CuresAdvisor to the National Bleeding Disorders Foundation2022New York, United States
  4. Royalty PharmaAdvisorcurrent2023 — presentNew York, United States
  5. Sealth Biotherapeutics CompanyNon-Executive Chair, Board of Directorscurrent2026 — present
  6. Sixty8 CapitalLimited Partnercurrent2021 — presentIndiana, United States
  7. PortfoliaInvesting Member - Rising America I, II and III Fund and FemTech II Fundcurrent2020 — present
  8. Spin-outs DenmarkAdvisory Board Membercurrent2021 — presentCopenhagen, Capital Region of Denmark, Denmark
  9. Lake Monroe Water FundBoard of Directorscurrent2023 — presentBloomington, Indiana, United States
  10. Cold Spring Harbor LaboratoryBusiness Development Advisorcurrent2020 — presentCold Spring Harbor, New York, United States
  11. Oncode InstituteInternational Advisory Board, Chair2018 — 2026The Randstad, Netherlands
  12. Spark Biomedical IncBoard Observer - FiveLiters a Pathway to Cures portfolio company2023 — 2024Dallas, Texas, United States
  13. Indiana University FoundationFounding Member, Black Philanthropy Circle2020 — 2024Bloomington, Indiana, United States
  14. IU VenturesAdvisor2022 — 2023
  15. IU VenturesManaging Director2018 — 2022Greater Bloomington Area
  16. Kovina TherapeuticsNon Executive Director2021 — 2022Indianapolis, Indiana, United States
  17. Diagnotes, Inc.Non Executive Director2019 — 2022Indianapolis, Indiana
  18. PeriodicNon Executive Director2019 — 2022Greater Bloomington Area
  19. The MillInvesting Member - Flywheel Fund I2020 — 2021Bloomington, Indiana, United States
  20. Cold Spring Harbor LaboratoryBusiness Development Advisor2018Cold Spring Harbor, New York
  21. Cold Spring Harbor LaboratoryVice President for Business Development & Technology Transfer2013 — 2018Cold Spring Harbor, New York
  22. Stoke TherapeuticsBoard Observer2015 — 2018Boston, Massachusetts, United States
  23. AUTMDirector2014 — 2016
  24. Mount SinaiVice President, The Mount Sinai Medical Center, Technology and Business Development2011 — 2013New York City
  25. Cambridge Enterprise, LtdDirector (NED)2011 — 2012Greater Cambridge Area
  26. Cambridge Enterprise, LtdFounding Chief Executive and Executive Director2006 — 2011Greater Cambridge Area
  27. ARCH Development Partners, LLCManaging Partner and Co-Founder2001 — 2008Chicago, IL
  28. University of Notre DameAdjuct Faculty2001 — 2005
  29. University of ChicagoVice President - ARCH Development Corporation1997 — 2001Chicago, IL
  30. Purdue Research FoundationDirector1991 — 1997
  31. AUTMPresident1996 — 1997
  32. Corporation for Science and TechnologyProject Manager1989 — 1991Indianapolis, Indiana
  33. Northwestern UniversityAssistant Director1985 — 1989Evanston, Illinois
  34. International Minerals and ChemicalManager1981 — 1985

Skills & more

Management16Strategy17Entrepreneurship58Biotechnology45Start-ups54Technology Transfer83Lifesciences51Innovation Management12Research18Intellectual Property20Licensing25Commercialization65
+12 moreBusiness DevelopmentProduct DevelopmentGenomicsDrug DiscoveryVenture CapitalHealthcareR&DBiochemistryMolecular BiologyInvestmentsPharmaceutical IndustryMedical Devices

From Teri's professional profile.

Colleagues at Pathway to Cures

Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Brian Andrew
Investment Committee Chair at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Gilbert C. White, II
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures

Frequently asked questions

Who is Teri Willey?
Willey joined NBDF in November 2022 to launch and lead Pathway to Cures. She has over 35 years of experience commercializing early-stage research, previously serving as founding managing director of IU Ventures' Indiana Philanthropic Venture Fund, founding chief executive of Cambridge Enterprise Ltd, and co-founder of ARCH Development Partners.
Where does Teri Willey work?
Teri Willey is P2C Managing Director & Officer at Pathway to Cures.
Where did Teri Willey go to school?
Teri Willey studied at Indiana State University (Masters Business Administration, Finance); University of Idaho (Bachelor's degree, Animal Sciences); Pocatello High School, Idaho.

Same school

Shared employers